Therapeuticsmd (TXMD) Stock
Specialty pharmaceutical developer focused on women's healthcare. Here's the price, business snapshot, and what's worth knowing about Therapeuticsmd in October 2026.
TherapeuticsMD, Inc. (TXMD) is a small-cap specialty pharmaceutical company focused on women’s healthcare. Investors should know it operates in a high-risk, research-driven segment where companies aim to develop, licence and commercialise therapies for specific patient groups. With a market cap of roughly $13.5m, TXMD is highly exposed to liquidity, clinical, regulatory and commercial execution risks; its share price may be volatile and dilution through additional financing is a realistic possibility. Potential upside could come from successful product launches, partnerships or favourable regulatory outcomes, but outcomes are uncertain. This summary is general educational information and not personal investment advice — consider suitability, your risk tolerance and consult a qualified adviser before acting. Past performance is not indicative of future returns and values can fall as well as rise.
Therapeuticsmd (TXMD) Stock Forecast
Analyst price target, next 12 months
$5.00
+143.9% vs today's $2.05
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Therapeuticsmd have a consensus 12-month target of $5.00, above the current price of $2.05.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 May 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying TherapeuticsMD stock with a target price of $5, indicating strong growth potential.
Financial Health
TherapeuticsMD Inc has modest revenue and cash flow, indicating stable yet unspectacular financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Small-cap volatility
Market cap underlines high price swings and limited liquidity; this can mean big gains or losses and possible share dilution.
Product development focus
Progress in clinical or regulatory milestones can materially affect value, though many programmes face setbacks or delays.
Commercial and partners
Partnerships or licensing can expand reach and revenue, but commercial execution and market uptake remain uncertain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
